Conference
NCIC CTG IND 113: two phase I dose escalation pharmacokinetic (PK) studies of BAY 12-9566 (BAY) in combination with either doxorubicin (DOX) or modulated 5-fluorouracil (FU)
Authors
Hirte H; Stewart D; Goel R; Chouinard E; Huan S; Elias I; Matthews S; Seymour L
Volume
35
Publisher
Elsevier
Publication Date
September 1, 1999
DOI
10.1016/s0959-8049(99)81556-1
Conference proceedings
European Journal of Cancer
ISSN
0959-8049